Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.389, 2002-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Losartan a "cost-effective intervention" for hypertension
Inpharma, Vol. 1, Iss. 1518, 2005-01 ,pp. :
Multicondition collaborative care intervention cost effective
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 655, 2012-01 ,pp. :
Vaccination of blood donors against hepatitis B is feasible, safe and cost–effective
Future Virology, Vol. 6, Iss. 10, 2011-10 ,pp. :
Self-monitoring of BP feasible, cost effective in the UK
Inpharma, Vol. 1, Iss. 1504, 2005-01 ,pp. :